In Some TAVR Patients, Cardiac Amyloidosis Picture Comes Into Focus

Columbia University Medical Center| Tue Aug 01 06:29:15 EDT 2017
In Some TAVR Patients, Cardiac Amyloidosis Picture Comes Into Focus

Technetium pyrophosphate uptake in the heart in a patient without heart failure and no history of cardiac amyloidosis (left) and in a patient with cardiac amyloidosis (right). 

Deposits of an abnormal protein in the heart may explain why some elderly patients benefit less than others from a heart valve replacement procedure, a new study from CUMC researchers has found.

Since its introduction in 2002, transaortic valve replacement (TAVR) has added years to the lives of patie....

Read at Source
Related News